JSM 2005 Online Program

Abstract #304075

This is the preliminary program for the 2005 Joint Statistical Meetings in Minneapolis, Minnesota. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2005); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

The Program has labeled the meeting rooms with "letters" preceding the name of the room, designating in which facility the room is located:

Minneapolis Convention Center = “MCC” Hilton Minneapolis Hotel = “H” Hyatt Regency Minneapolis = “HY”

Back to main JSM 2005 Program page

Legend:

= Applied Session,

= Theme Session,

= Presenter

Activity Number:	279
Type:	Luncheons
Date/Time:	Tuesday, August 9, 2005 : 12:30 PM to 1:50 PM
Sponsor:	Biopharmaceutical Section
Abstract - #304075
Title:	Significant Sequence Effect in a Crossover Design
Author(s):	Anna Nevius*+
Companies:	U.S. Food and Drug Administration
Address:	7500 Standish Place, Rockville, MD, 20855, United States
Keywords:	crossover design ; sequence effect
Abstract:	If the sequence effect is significant in a two-treatment, two-period, two-sequence crossover design, how does one proceed in analyzing the study? What conditions should be present to be able to use the data from both periods?

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2005 program